Back to results

Non-invasive imaging of tumor pd-l1 expression using radiolabeled anti-pd-l1 antibodies

The present invention relates to a method for identifying patients suffering from or suspected to suffer from a cancer involving a solid tumor
Keywords: PD-L1, imaging, radiolabel
Patent Application number: European Procedure (Patents) (EPA) - 07 Avr. 2015 - 15305510.8
Inventors:
null
Publications:
null

Reference:

BIO15048-T1

    Business Developper
    contact
    Inserm Transfert
    Business Developer
    Patent filling date: 07-04-2015
    Rare disease: No
    Second indication: No

    You might also be interested in